Intraocular Pressure and Anterior Segment Morphometry Changes after Uneventful Phacoemulsification in Type 2 Diabetic and Nondiabetic Patients

Table 1

Demographic and clinical characteristics of the study population.

	DM group (n = 45)	Non-DM group (n = 44)
Age (y)	72.7 ± 5.7	70.6 ± 6.3	0.106^1
Female (n)	28 (63%)	27 (61%)	0.934^3
Right eyes (n)	22 (49%)	29 (66%)	0.105^3
BMI (kg/m^2)	28.2 ± 3.9	27.9 ± 5.2	0.763^1
Smoking history (n)	10 (22%)	17 (39%)	0.092^3
HbA1c levels (%)	6.8 ± 1.0	5.5 ± 0.4	<0.001
Duration of diabetes (y)	9.1 ± 8.0	n/a	n/a
DR stage (n)
No apparent DR	39 (87%)	n/a	n/a
Mild to moderate NPDR	6 (13%)
Oral antidiabetic agents (n)	43 (96%)	n/a	n/a
Insulin treatment (n)	7 (16%)	n/a	n/a
Axial length (mm, preoperatively)	22.9 ± 0.7	23.0 ± 0.8	0.8551
Intraoperative data
Cataract grade	1.6 ± 0.6	1.9 ± 0.6	0.032
CDE	9.3 ± 7.1	9.3 ± 6.4	0.997^1
IOL power	22.1 ± 1.6	22.2 ± 1.8	0.687^2
Acrysof®/Akreos®	37/8	38/6	0.592^3

Data were derived from independent samples t-test¹, Mann–Whitney test², and chi-square³ test. Continuous variables are reported as mean ± standard deviation. , statistical significance. BMI, body mass index; CDE, cumulative dissipated energy; DM, diabetes mellitus; DR, diabetic retinopathy; NPDR, nonproliferative DR; IOL, intraocular lens; mm, millimeters; n/a, not applicable; y, years.